Police leadership in public health: what do we get? G e o f f r e y M O N A G H A N Police Leadership in Public Health What Do We Get? Workshop 11-13 December.

Slides:

Advertisements

Similar presentations

Daliah Heller, PhD, MPH Assistant Commissioner

Advertisements

Workshop IV: Provision of Health Care The Impact of International Standards and Guidelines on prisoner health in Eastern and Central Europe Antalya, Turkey.

Glasgow Involvement Group Views from injecting drugs users in Glasgow Pathways to Treatment and Care Conference Stirling Royal Infirmary 30 th September.

Turning the tide: Not without prisons! Promoting comprehensive national HIV responses.

Police leadership in public health G e o f f r e y M O N A G H A N Police Leadership in Public Health Seminar December 2013 Semeion Research Center for.

Strategic, service provider and user responses to reducing fatal and non-fatal poisonings Rowan Williams, Development Manager, Drugaid.

2 emcdda.europa.eu European drug report package A comprehensive analysis on the drugs problem in Europe.

MDM Harm Reduction (needle exchange) program in Kabul-Afghanistan.

Integrated Drug Treatment System lessons learned from implementation.

Models of Harm Reduction

San Francisco Bay Area Drug Trends and Effective Intervention Strategies Alice Gleghorn, Ph.D County Alcohol and Drug Program Administrator San Francisco.

GAP Report 2014 Prisoners People left behind: Prisoners Link with the pdf, Prisoners.

Opioid Safety Phillip Coffin, MD, MIA Director of Substance Use Research San Francisco Dept. of Public Health Assistant Clinical Professor University of.

Addiction Treatment Outcomes Prof Michael Gossop National Addiction Centre Maudsley Hospital/Institute of Psychiatry.

Slide 5.1 Topic 5. Supporting programs aimed at reducing the spread of HIV among and from IDU Needle and Syringe Programs Opioid Substitution Treatment.

Presentation ‘Developing positive working relationships between Health and Law Enforcement Agencies’

Leadership Institute Branch Legal Training Section SB HEROIN 2015 Kentucky General Assembly Roll Call Training

Copyright Alcohol Medical Scholars Program 1 Opioid Agonist Treatment: “Trading one substance for another?” Joseph Sakai, M.D.

HIV Prevention, treatment and care among people who inject drugs Fabienne Hariga, MD, MPH Senior HIV Adviser, UNODC Vienna.

1 Description of the addiction service of the Republic of Uzbekistan Jur’at Umargaliev Ministry of Health.

California Department of Public Health Office of AIDS Access to Sterile Syringes: Changes to California Law Alessandra Ross, MPH InjectionUse Specialist.

Overview of Syringe Exchange Programs New York City Police Academy November 24, 2004.

WISCONSIN STATE COUNCIL ON ALCOHOL AND OTHER DRUG ABUSE PREVENTION COMMITTEE 911 GOOD SAMARITAN AD-HOC COMMITTEE SKYE TIKKANEN, MS, NCC, CSAC, LPC-IT CO-CHAIR.

The UK Drugs Situation: Data, information and uses Charlotte Davies, UK Focal Point Project Manager 1.

 Insufficient Reliable data in this region  Estimated people living with HIV  The number of new HIV infections in the region increased.

Injection drug users’ knowledge about overdose prevention and take home Naloxone in Ukraine. ICF 'International HIV/AIDS Alliance in Ukraine Liudmyla Shulga.

Harm Reduction.

Overview of Harm Reduction and Sterile Syringe Access Anna Benyo Syringe Access Policy Coordinator Harm Reduction Coalition New Jersey Syringe Access Informational.

Naloxone (Narcan) A true opioid overdose antidote.

Recommendations on the Management of Opioid Overdose Ruth Birgin.

HARM REDUCTION RESPONSES TO DRUGS IN THE EUROPEAN UNION – FROM MARGIN TO MAINSTREAM 8 th Annual Meeting of the European Red Cross / Red Crescent Network.

Overview of Drug Control in Foreign Countries. Drug Control in EU A. Policy Trends ■ Decriminalisation of possession of small amount of drugs for personal.

Saves Lives Oklahoma’s Plan to Reduce Prescription Drug Abuse and Prevent Overdose.

NEEDLE AND SYRINGE PROGRAMMES IN THE UK Jamie Bridge, NNEF Chair

Washington D.C., USA, July 2012www.aids2012.org Human rights as a key component of harm reduction strategy targeting people using drugs in Morocco.

Overdose: A major preventable cause of death in Eastern Europe and Central Asia Shona Schonning.

Understanding Drug Abuse and Addiction: What Science Says Developed by the National Institute on Drug Abuse (NIDA) National Institutes of Health Bethesda,

Buprenorphine Treatment for Opioid Dependence CESAR FAX U n i v e r s i t y o f M a r y l a n d, C o l l e g e P a r k A Weekly FAX from the Center for.

1 People who use drugs, HIV, and human rights The Lancet : HIV in people who use drugs Vienna, 20 July 2010 Ralf Jürgens Joanne Csete, Joe Amon Steven.

Project RAS/H13 “Prevention of transmission of HIV among drug users in SAARC Countries” Lubna Mohamed Zahir Hussain Chairperson of National Drug Agency.

Groups and subgroups of drug users Presentation 6.

School of Public Health and Community Medicine How policies and repressive law- enforcement fuel the HIV epidemic among people who inject drugs Professor.

Maryland’s “Good Samaritan” Law Annotated Code of Maryland, Criminal Procedure §1-210 Effective October 1, 2015 September

Substance Abuse Treatment and HIV in Iran

Neil Hunter Community Services Manager – Glasgow Addiction Service Strategic approach to drug deaths.

Heroin Rising: the Resurgence of Heroin and Opiate Abuse

Harm Reduction Team Maureen Woods Team Leader. Service Delivery Aims Develop harm reduction initiatives in partnership with other agencies to reduce the.

Substance Misuse Treatment Framework – Needle Exchange Implications for planning and practice Carry Burton North Wales Needle Syringe Programme & Harm.

Developing an integrated approach to the issues of drug use and homelessness – the experience from the frontline. Mark Kennedy Head of Day Services, Merchants.

Opiate overdose. Opiate overdose (ONS, 2012) The most common acute cause of drug-related death is opiate overdose. Over half – 596 (57 per cent) - of.

Bystander Naloxone Training Saves Lives. Death rates are spiraling out of control--for both prescription opioids and heroin! Graphic: Nytimes.com.

PREVENTION OF DRUG ABUSE AMONG VULNERABLE GROUPS Dr Marcus Roberts Director of Policy and Membership DRUGSCOPE.

Collaboration between the national EWS and treatment service providers in Hungary Anna Péterfi Hungarian National Focal Point TAIEX seminar Zagreb,

Drug-related deaths Phil Conley Health Improvement Programme Manager September 2015.

HOPE Agenda Heroin, Opioid Prevention & Education WISCONSIN STATE REPRESENTATIVE JOHN NYGREN – ASSEMBLY DISTRICT 89.

The Aviator Hotel – South Africa Uganda Harm Reduction Network (UHRN)

Missouri Network for Opiate Reform and Recovery

10th Annual Susan Li Conference

Medication-Assisted Therapy at Coleman Profession Services

Responding to Overdose

Cabarrus County Substance Abuse

Addressing Drug Use Together Through a Health Based Approach:

Harm Reduction 24/7: The supply of harm reduction materials via vending machines for drug users in North Rhine-Westphalia, Germany. Prof. Dr. Daniel.

Henry L. Dorkin, MD, FAAP President, Massachusetts Medical Society

Reitox National Focal Point National Bureau for Drug Prevention

Towards a Conducive Legal and Structural Environment

There are over 200 syringe access service programs (SSP) in the United States. These programs provide sterile syringes to people who inject drugs and.

QC Harm Reduction Opioid Overdose Reversal Training

State Response to Opioids and Infectious Disease

Human Dignity and Harm Reduction

Presentation transcript:

police leadership in public health: what do we get? G e o f f r e y M O N A G H A N Police Leadership in Public Health What Do We Get? Workshop December 2013 Semeion Research Center for the Science of Communication

reduction in crime G e o f f r e y M O N A G H A N Police Leadership in Public Health What Do We Get? Workshop December 2013  Methadone maintenance treatment programmes are very effective in reducing acquisitive crime rates, opiate consumption and heroin supply offences See, for example: Jeremy Coid, J., Carvell, A., Kittler, Z., Healey, A. and Henderson, J. (2000) Opiates, Criminal Behaviour and Methadone Home Office, London.

reduction in opiate overdose deaths G e o f f r e y M O N A G H A N Police Leadership in Public Health What Do We Get? Workshop December 2013  Supporting ‘take-home-naloxone’ – ‘Good Samaritan’ laws  Training police officers to administer naloxone  First Aid Training – recruits and top-up training  Treating drug swallowing as a medical emergency requiring hospitalisation

reduction in HIV and hepatitis G e o f f r e y M O N A G H A N Police Leadership in Public Health What Do We Get? Workshop December 2013  NSPs are effective in preventing HIV and hepatitis B and C

improved public image G e o f f r e y M O N A G H A N Police Leadership in Public Health Workshop December 2013  Supporting, and being seen to support public health programmes, will help improve the standing of the Royal Malaysia Police

bolster informant network G e o f f r e y M O N A G H A N Police Leadership in Public Health Workshop December 2013  Being ‘nice’ to drug users (particularly those who inject drugs) works wonders in terms of gleaning intelligence and recruiting informants

cost savings G e o f f r e y M O N A G H A N Police Leadership in Public Health Workshop December 2013  Crime reduction on the cheap (methadone maintenance treatment)  Reduction in the number of investigations into drug overdose deaths  Reduction in the fear of crime (e.g. people who inject drugs using NSPs instead of going to pharmacies hassling staff for syringes and injecting paraphernalia)

G e o f f r e y M o n a g h a n